Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Something went wrong, try again later.
Matched clinical trials
Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations
Not recruiting
2 1 1 1Investigated Diseases:Investigated Drugs:
Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer
Not recruiting
2 1 1 1Investigated Diseases:Investigated Drugs:
Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
Not recruiting
3 1 1 1Investigated Diseases:Investigated Drugs:
+8
Study on the Safety of ARV-471 and Everolimus for Patients with Advanced or Metastatic ER+, HER2- Breast Cancer
Not recruiting
1 1 1 1Investigated Diseases:Investigated Drugs:
Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
Not recruiting
3 1 1Investigated Diseases:Investigated Drugs:
+2
Study of BB-1701 for Patients with HER2-positive or HER2-low Metastatic Breast Cancer
Not recruiting
2 1 1Investigated Diseases:Investigated Drugs:
Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma
Not recruiting
1 1 1Investigated Diseases:Investigated Drugs:
Study of Abemaciclib and Tamoxifen in Women with Metastatic Breast Cancer
Not recruiting
2 1 1 1


